Clare Chui Ling Sun MD

Oncology•Basking Ridge, NJ

Hematologic Oncology

Associate Attending Physician, Memorial Sloan Kettering Cancer Center

Request appointment

136 Mountainview BlvdBasking Ridge, NJ 07920
Book by Phone+1(320) 377-3659

Overview of Dr. Sun

Dr. Clare Sun, based in Bethesda, MD, is an oncologist specializing in hematologic oncology. She completed her residency in Internal Medicine at Loyola University Medical Center and her fellowship in Hematology and Medical Oncology at the National Institutes of Health Clinical Center. Dr. Sun earned her medical degree from the University of British Columbia in 2010. Her research focuses on chronic lymphocytic leukemia (CLL), with publications addressing various aspects such as the tumor microenvironment, vaccination, and infectious complications. Her work has appeared in esteemed journals like Blood, Seminars in Hematology, and Clinical Cancer Research.

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
Loyola University Medical CenterResidency, Internal Medicine, 2010 - 2013
University of British ColumbiaClass of 2010

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MD State Medical License 2013 - 2027
NJ State Medical License 2025 - 2027
NY State Medical License 2025 - 2027
DC State Medical License 2014 - 2016
IL State Medical License 2010 - 2013
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers Start of enrollment: 2010 Jun 03
COMPLETED

Publications & Presentations

PubMed

A decade of ibrutinib for CLL with and without TP53 aberration: final report on an investigator-sponsored phase 2 study.
Andy Itsara, Victoria M Rogness, Laura Samples, Constance M Yuan, Hao-Wei Wang
Blood. 2026-04-09
Sudden death and asymptomatic arrhythmia in chronic lymphocytic leukemia patients treated with ibrutinib.
Emily Tomasulo, Andy Itsara, Mark Haigney, Douglas R Rosing, Inhye E Ahn
Heart Rhythm. 2026-03-01
1 citations
Activation and exhaustion of CD8 T cells in patients with chronic lymphocytic leukemia treated with ibrutinib and pembrolizumab.
Rui Mu, Katherine M Hornick, Neelam Redekar, Jonathan Chen, Pia Nierman
Journal of Immunology. 2025-11-01

Abstracts/Posters

Phase 1 Trial of Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocytic Leukemia
Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib Show Expansion of T-Cell Clonotypes Composed of Antitumor Cytotoxic CD8+ T-Cells
Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Diverging Clonal Evolution during Sequential Therapy with Chemoimmunotherapy Followed By BTK Inhibitors
Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Spatial Genomic Heterogeneity in Chronic Lymphocytic Leukemia
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Partial Reconstitution of Humoral and Cellular Immunity in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Ibrutinib Increases the Clonality of TCR Repertoire in Patients with Chronic Lymphocytic Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018